A safety alert by hip implant manufacturer Stryker reveals that certain sizes of their LFIT V40 Hip implant may rupture. The company received a higher than expected number of charges stating that the femoral head broke free of the stem that connects it to the thigh bone requiring a revision surgery.
Stryker identified eight sizes of LFIT V40 femoral heads that may cause complications and informed health centers to alert the patients. The FDA will decide in a month or two whether to consider a recall for the product or not. An earlier Class II recall by FDA in 2016 affected more than 42,500 Stryker hip replacement products.
Cases against Stryker hip replacement systems are consolidated as a part of multidistrict litigation, MDL No. 2768 ( In Re: Stryker LFIT V40 Femoral Head Products Liability Litigation) in the United States District Court for the District of Massachusetts before U.S. District Judge Indira Talwani.